160 related articles for article (PubMed ID: 33738875)
21. Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other High-Risk HPV Types in Oropharyngeal Squamous Cell Carcinoma.
Shenker RF; May NH; Waltonen JD; Yang JP; O'Neill SS; Frizzell BA; Greven KM; Hughes RT
Head Neck Pathol; 2021 Sep; 15(3):866-874. PubMed ID: 33616854
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Kwon S; Ahn SH; Jeong WJ; Jung YH; Bae YJ; Paik JH; Chung JH; Kim H
J Transl Med; 2020 Jun; 18(1):240. PubMed ID: 32546279
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
[TBL] [Abstract][Full Text] [Related]
24. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
[TBL] [Abstract][Full Text] [Related]
25. HPV Infection in Squamous Cell Carcinoma of the Hypopharynx, Larynx, and Oropharynx With Multisite Involvement.
Kuga R; Yamamoto H; Jiromaru R; Hongo T; Yasumatsu R; Matsuo M; Hashimoto K; Taniguchi M; Nakagawa T; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):955-966. PubMed ID: 37357948
[TBL] [Abstract][Full Text] [Related]
26. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
[TBL] [Abstract][Full Text] [Related]
27. Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options.
Modesto A; Siegfried A; Lusque A; Vergez S; Sarini J; Brouchet L; Uro-Coste E; Graff-Cailleaud P; Delord JP
Curr Oncol; 2021 Apr; 28(3):1673-1680. PubMed ID: 33947015
[TBL] [Abstract][Full Text] [Related]
28. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
[TBL] [Abstract][Full Text] [Related]
29. Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas.
Carlander AF; Bendtsen SK; Rasmussen JH; Jakobsen KK; Garset-Zamani M; Grønhøj C; Friborg J; Hutcheson K; Johnson FM; Fuller CD; Moreno AC; Babarinde T; Gross ND; Myers JN; von Buchwald C
Eur J Cancer; 2024 May; 202():113983. PubMed ID: 38452723
[TBL] [Abstract][Full Text] [Related]
30. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
31. Aptima HR-HPV Testing of Cytology Specimens Is an Effective Supplement for p16 Staining to Improve Diagnostic Accuracy for HPV-Related Oropharyngeal Squamous Cell Carcinoma.
Yang X; Hu C; Zhao H; Zhang Z; Zhao L; Yu J; Ni X; Guo H
Acta Cytol; 2023; 67(3):321-332. PubMed ID: 36513056
[TBL] [Abstract][Full Text] [Related]
32. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
[TBL] [Abstract][Full Text] [Related]
33. CD8+ T Cells and PD-L1 Expression as Prognostic Indicators in a Low Prevalence of HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Atipas K; Laokulrath N; Petsuksiri J; Ratanaprasert N; Pongsapich W
Curr Oncol; 2023 Jan; 30(2):1450-1460. PubMed ID: 36826072
[TBL] [Abstract][Full Text] [Related]
34. A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
Balk M; Rupp R; Sievert M; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Eckstein M; Iro H; Hecht M; Gostian AO
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5489-5497. PubMed ID: 37505261
[TBL] [Abstract][Full Text] [Related]
35. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of human papillomavirus detection and the eighth edition of the TNM classification staging system in oropharyngeal squamous cell carcinoma: A single-center Polish study.
Durzynska M; Kiprian D; Szumera-Cieckiewicz A; Leszczynski P; Florek A; Snietura M; Michalek IM; Bakula-Zalewska E; Prochorec-Sobieszek M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):698-705. PubMed ID: 35165063
[TBL] [Abstract][Full Text] [Related]
37. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
[TBL] [Abstract][Full Text] [Related]
39. Impact of Nodal Metastases in HPV-Negative Oropharyngeal Cancer.
Chang CM; Chen MM; Bellile EL; Rozek LS; Carey TE; Spector ME; Wolf GT; Taylor JM; Chinn SB
Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1554-1563. PubMed ID: 35579907
[TBL] [Abstract][Full Text] [Related]
40. Human Papillomavirus Impact on Temporal Treatment Trends in Oropharyngeal Carcinoma: 2010-2016.
Amin N; Thompson J; Goloubeva O; Witek M; Taylor RJ; Wolf JS; Moyer K; Mehra R; Hatten KM
ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):438-446. PubMed ID: 36067748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]